Our findings revealed that two of the genes represented by these transcripts (FERMT3‐208 and UBE2F‐207) exhibit a significant negative correlation with the overall survival in AML (Figure 4F–I). This evidence concerns the gene FERMT3 and acute myeloid leukemia.